Surgery first versus IVF-first for people with advanced endometriosis
Official title: First Line Surgery or First Line Fertility Treatment Using Assisted Reproductive Technologies in Patients With Advanced Endometriosis: A National Multicenter Randomized-controlled Trial
Run by Karolinska Institutet · NCT07240363 · Data updated 2026-11-12
This trial will test whether having surgery before assisted reproductive technologies (like IVF) or going straight to IVF gives people with advanced endometriosis a better chance of pregnancy and live birth.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 38 Years |
| Sex | Women only |
| Enrollment | 350 (estimated) |
| Sponsor | Karolinska Institutet Academic / other |
| Locations | 4 sites (Stockholm, Stockholm County and 3 other locations) |
| Status | Recruiting |
| Started | October 6, 2025 |
| Main results expected | September 22, 2028 |
| Study ends | September 22, 2031 |
| Registry record updated | November 20, 2025 |
| Trial ID | NCT07240363 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people aged 18–38 with AAGL stage III–IV endometriosis, BMI 18–35, referred or eligible for ART, who have not had prior endometriosis surgery beyond diagnostic laparoscopy or prior IVF/ICSI and who can give informed consent.
✕Probably not a fit
Patients with prior endometriosis surgery or prior IVF, hydrosalpinx, clear urgent surgical indications, suspected malignancy, large fibroids, or significant uterine malformations are unlikely to benefit or are ineligible for this comparison.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional trial compares two first-line approaches for people with advanced (AAGL stage III–IV) endometriosis who want fertility treatment: surgical removal of endometriosis lesions prior to assisted reproductive technologies (ART) versus proceeding directly to ART (for example IVF/ICSI). Eligible participants (age 18–38, BMI 18–35, no prior endometriosis surgery beyond diagnostic laparoscopy, and no prior IVF/ICSI cycles) will be assigned to either surgery followed by ART or to immediate ART and followed for pregnancy and live birth outcomes. Major exclusions include hydrosalpinx, clear indications for immediate surgery, suspected malignancy, large or certain fibroids, and uterine malformations. The study will use reproductive outcomes such as clinical pregnancy and live birth rates to determine whether pre-ART surgery improves chances of having a child compared with ART alone.
Why it matters
Potential benefit: If successful, the trial could clarify whether surgery before ART increases pregnancy and live birth rates and thus guide the best first-line approach for people with advanced endometriosis and infertility.
How similar studies have gone: A small number of observational studies and one meta-analysis have suggested that surgery before IVF may improve pregnancy and live birth rates, but randomized evidence is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 - 38 years old * Endometriosis AAGL stage III-IV * Referred or eligible for ART-treatment such as IVF or ICSI, independent of infertility diagnosis (28) (including sperm donation cycles for social reasons) and/or infertility due to dyspareunia/dysmenorrhea caused by endometriosis * Body mass index 18-35 kg/m2 * Patients who have signed an approved Informed Consent Exclusion Criteria: * Previous surgery for endometriosis except diagnostic laparoscopy. * Previous IVF/ICSI-cycles (including prior fertility preservation cycles) * Hemato- and/or hydrosalpinx * Clear indication for surgery such as ureteral stenosis or intestinal sub-occlusive symptoms * Suspicion of malignancy * Submucosal fibroids (The International Federation of Gynecology and Obstetrics (FIGO) 0-1, any size) or intramural fibroids (FIGO 2-5, \> 4 cm largest diameter of the largest myoma) (29) * Uterine malformations (class U1-U6 according to ESHRE/ESGE-classification) (30) * Patients with contraindications to surgery * Patients undergoing ART with donated oocytes
Where it's running
-
Sodersjukhuset
Stockholm, Stockholm County, Sweden Recruiting -
Sahlgrenska University Hospital
Gothenburg, Västra Götaland County, Sweden Not yet recruiting -
Skåne university hospital, Malmö
Malmö, Sweden Not yet recruiting -
Uppsala University Hospital, Uppsala
Uppsala, Sweden Not yet recruiting
Study contacts
- Principal investigator: Malin Brunes, MD, PhD — Karolinska Institutet
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing different techniques to treat endometriosis
This study is testing different methods to treat endometriosis, like laser and heat techniques, to see which one works best for relieving pain in women who are already having surgery for the condition.
-
Postoperative Pain Trajectories After Endometriosis Surgery
This study tests how pain changes after endometriosis surgery and whether perioperative pain testing can predict who will have ongoing pain.
-
Imaging endometriosis with a special PET tracer in adult women
This study tests whether a PET/CT scan using [18F]AlF-FAPI-74 can help detect endometriosis lesions in women who are planning laparoscopy.
-
Fiber supplement for digestive symptoms in endometriosis
A fiber-based supplement is being tested to see if it is safe and helps with gut and vaginal microbiomes and digestive symptoms in women with endometriosis.
-
Dual Trigger vs HCG Trigger for Final Maturation in Normal Responders
In normal responders undergoing ICSI cycles, this study tests whether using a dual trigger (GnRH agonist plus hCG) improves outcomes compared with the standard hCG trigger.
-
Stellate ganglion block and dexmedetomidine for better sleep after gynecologic laparoscopy
The study tests whether giving a preoperative stellate ganglion block plus intraoperative dexmedetomidine improves sleep after laparoscopic gynecologic surgery in women.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.